Open access · CC-BY
via OpenAlex
Inhibition of mesenchymal drift as a strategy for rejuvenation
Frontiers in Pharmacology · 2025
Abstract
Mesenchymal drift (MD), the progressive acquisition of mesenchymal traits by epithelial and endothelial cells, has emerged as a unifying mechanism of aging. Transcriptomic analyses across human tissues reveal that mesenchymal programs intensify with age and predict morbidity and mortality. By eroding lineage identity and promoting fibrosis, MD disrupts organ integrity in the lung, liver, kidney, heart, and brain. Mechanistically, it converges with epigenetic erosion, chronic inflammation, and extracellular matrix stiffening to establish self-reinforcing loops of dysfunction. Interventions that restore cellular identity can suppress MD: transient reprogramming resets epigenetic age and reduces fibrotic signatures without loss of identity, while chemical cocktails achieve similar rejuvenation effects with enhanced translational potential. Together, these findings establish MD as a tentative hallmark of aging and suggest that its inhibition could represent a strategy for cellular and tissue rejuvenation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fphar.2025.1715559
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Camillo, L.P.D.L. (2025). Inhibition of mesenchymal drift as a strategy for rejuvenation. <em>Frontiers in Pharmacology</em>. https://doi.org/10.3389/fphar.2025.1715559
Vancouver
Camillo LPDL. Inhibition of mesenchymal drift as a strategy for rejuvenation. Frontiers in Pharmacology. 2025. doi:10.3389/fphar.2025.1715559.
BibTeX
@article{lucas2025Inhibi,
title = {Inhibition of mesenchymal drift as a strategy for rejuvenation},
author = {Lucas Paulo de Lima Camillo},
journal = {Frontiers in Pharmacology},
year = {2025},
doi = {10.3389/fphar.2025.1715559},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in pharmacology 2025
Open access · OA
Inhibition of mesenchymal drift as a strategy for rejuvenation.
Journal of Dental Research 2024
Open access · CC-BY
Molecular Signatures of Senescence in Periodontitis: Clinical Insights
Neurology International 2025
Open access · CC-BY
Senotherapeutics for Brain Aging Management
Neurology international 2025
Open access · OA
Senotherapeutics for Brain Aging Management.
Journal of Clinical Investigation 2018
Open access · OA
Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives
Cells 2022
Open access · CC-BY